Multiple Assemblies exist for SMTL entry 3ook
Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3,5-difluorobenzoic acid; X-RAY DIFFRACTION 2.29 Å

SMTL ID
3ook.1
Ligands
4-({(2S)-2-[2-(4-CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYLACETYL}AMINO)-3,5-DIFLUOROBENZOIC ACID
Polypeptides
Bile acid receptor; peptide of Nuclear receptor coactivator 1
Oligo-state
hetero-oligomer
SMTL ID
3ook.2
Ligands
4-({(2S)-2-[2-(4-CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYLACETYL}AMINO)-3,5-DIFLUOROBENZOIC ACID
Polypeptides
Bile acid receptor; peptide of Nuclear receptor coactivator 1
Oligo-state
hetero-oligomer